focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.50
Bid: 38.00
Ask: 39.00
Change: -2.05 (-4.91%)
Spread: 1.00 (2.632%)
Open: 43.50
High: 39.70
Low: 39.70
Prev. Close: 41.75
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: MetalNRG hails Gold Ridge findings

Thu, 09th Nov 2023 13:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

MetalNRG PLC - London-based natural resources and energy-focused investor - Says results from geologic soil sampling programme at Gold Ridge property in Arizona, US "support its previous belief that there is a real possibility of a larger undiscovered gold/base metal system". Programme finds "strong gold, copper, lead and zinc mineralisation related to the Mascot Stock". There is also "Strong gold, silver, arsenic, lead and zinc mineralisation related to the Apache Pass Shear zone". Tests also show a new gold, copper, lead and zinc trend in the Precambrian block. Executive Director Rolf Gerritsen says: "We are delighted with these results which confirm that whilst there is follow up work to be carried out, there is a real gold and indeed wider opportunity at Gold Ridge."

----------

Panthera Resources PLC - gold explorer and developer with assets in India and West Africa - Australian unit Indo Gold Pty Ltd preparing to deliver notice of dispute to India's government. Delivery is expected in the fourth-quarter of the year. The dispute concerns an alleged breach by India of a treaty with Australia on the Promotion & Protection of Investments. Panthera adds: "Following the delivery of the notice of dispute and in the absence of any meaningful correspondence in relation to this matter from the government of India or if no amicable settlement is reached, IGPL will subsequently deliver a notice of arbitration to the government of India. Any such notice of arbitration is anticipated to be delivered to the government of India in the first quarter of 2024. Under the Treaty, an arbitral tribunal is to be constituted within two months of delivery of the notice of arbitration." Panthera also notes a Times of India report that the gold deposit at the Bhukia asset "could be worth over USD1 billion", based on information from the Geological Survey of India. Panthera adds: "This valuation has not been independently verified by the company. Accordingly, while at this stage the company is not able to make any comments in relation to the potential quantum of damages that IGPL will claim from India, the company will in due course, announce the actual quantum of damages that IGPL will claim from India when available."

Panthera first invested in Bhukia, via its Australian unit, back in January 2005. A prospecting licence at the asset was rejected by the government of Rajasthan in August 2018 on "various spurious and legally untenable grounds", according to Panthera. Under the terms of an act passed in India in 2021, Panthera believes it has the rights to "fair and equitable compensation, not merely reimbursement of expenditures".

----------

United Oil & Gas PLC - oil and gas company focused on Egypt and Jamaica - In Jamaica, it notes it is currently engaged in discussions with a preferred potential partner to work alongside United Oil in the Walton Morant licence. United Oil adds: "Furthermore, the company is engaging with the Jamaican authorities to secure an extension to the current licence period which expires at the end of January 2024, so as to provide sufficient time to progress additional technical work on the block to support the drilling of an exploration well." In Egypt, working interest production averages 1,024 barrels of oil equivalent per day for the year to November 5, in line with 2023 outlook between 930 to 1,030 boepd. United Oil adds: "The full-year guidance includes production from the current wells and contributions from workover activity currently being undertaken on the fields." It cautions that the macroeconomic environment in Egypt, characterised by reduced US dollar liquidity as deteriorated. Less US dollar liquidity has impacted its ability to repatriate funds from Egypt. "Whilst Egyptian General Petroleum Corp has continued to make regular payments to the company against the receivable balance, including Egyptian pound payments equivalent to USD1.8 million since the 31 October, no USD payments have been received since August 2023," United Oil says.

----------

PCI-PAL PLC - Suffolk, England-based global cloud provider of secure payment solutions for business communications - Revenue in financial year ended June 30 increases 25% to GBP14.9 million from GBP11.9 million. Pretax loss widens to GBP4.9 million from GBP3.1 million, however. Administrative expenses climb 37% to GBP17.9 million. Non-Executive Chair Simon Wilson says: "I continue to be both excited and encouraged by the progress that has been made by the group in FY23, and the board is confident in the outlook and prospects in FY24 and beyond. Given the momentum in the business I look forward to sharing further progress reports and news during the coming year, as we continue our strategic growth journey towards profitability and further scale."

----------

Concurrent Technologies PLC - Essex, England-based designer and manufacturer of computer boards - Launches its "highest performance plug in card" yet. The new offering has "enhanced operational performance unlocked using an emerging cooling technology". It adds: "Previously, the PIC was cooled via conduction, while the new variant uses air flowing through a heat exchanger built into the product. This heat exchanger has been optimised using thermal simulations and verified through extensive testing to ensure it operates at peak performance under harsh environmental conditions. The benefit for customers is that they can extract more performance from the same physical card."

----------

Sareum Holdings PLC - Cambridge, England-based biotechnology firm - Announces first dosing of patients in food effect part of phase 1a probe of autoimmune therapy SDC-1801. This portion of the study probes how food consumption changes, if at all, the efficacy of the product. It will help determine whether the product must be taken on an empty stomach, for example. SDC-1801 will have an initial focus on psoriasis, an autoimmune condition affecting the skin.

----------

Amala Foods PLC - cash shell - Shares in the company are temporarily suspended as it enters into a binding agreement that could lead to reverse takeover of healthcare firm Dialysis Care Plus Inc. DCP is "building dialysis centres in the Philippines where the market for dialysis services is growing substantially every year". Amala adds: "The team has an excellent track record with internationally known healthcare groups in the USA as well as locally in the Philippines. The valuation approach that is being considered is one whereby upon a successful transaction the valuation paid would be based upon a share consideration and a deferred share consideration determined by financial performance. The company expects to conclude matters shortly and will provide further updates to the market this month." For the half-year ended September 30, the company reports a pretax loss of GBP39,602, narrowing from GBP82,631 12 months earlier. Loss is solely down to administrative expenses, which fall 57% from GBP91,327.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
7 Dec 2023 14:31

UK shareholder meetings calendar - next 7 days

Friday 8 December 
Amedeo Air Four Plus LtdAGM
Ashoka India Equity Investment Trust PLCAGM
Associated British Engineering PLCAGM
Associated British Foods PLCAGM
Corcel PLCGM re disposal of 41% interest in the Mambare nickel/cobalt project
Hargreaves Lansdown PLCAGM
URA Holdings PLCGM re closing the fundraise
Monday 11 December 
IamFire PLCAGM with vote on name change to WeCap PLC
Pharma C Investments PLCGM re allowing investments in fintech, AI sectors
SigmaRoc PLCGM re reverse takeover
Tribal Group PLCGM re cash offer by Tiger Bidco 1 Ltd
Vela Technologies PLCAGM
Tuesday 12 December 
Atalaya Mining PLCEGM re redomiciliation to Spain from Cyprus
Blackrock Greater Europe Investment Trust PLCAGM
Distil PLCGM re placing and subscription
Gelion PLCAGM
Wednesday 13 December 
Dechra Pharmaceuticals PLCAGM
Limitless Earth PLCAGM
Softcat PLCAGM
Volution Group PLCAGM
Thursday 14 December 
Aeorema Communications PLCAGM
CleanTech Lithium PLCGM re equity raise approval
Driver Group PLCFull Year Results
eEnergy Group PLCAGM
Ethernity Networks LtdGM re authority to allot shares on non-preemptive basis
Fintech Asia LtdAGM
Helium One Global LtdAGM
Marwyn Value Investors LtdAGM
Quarto Group IncGM re cancelling trading on London's Main Market
Sareum Holdings PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
23 Nov 2023 14:28

IN BRIEF: Sareum Holdings draws down on equity prepayment facility

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company, focused on developing kinase inhibitors to treat autoimmune diseases and cancer - Says that it has drawn down on the GBP300,000 second deposit in respect of a previously announced equity prepayment facility.

Read more
3 Nov 2023 13:59

Sareum secures Japan patent for kinase inhibitor asset

(Sharecast News) - Biotechnology firm Sareum announced on Friday that it has received a notice of allowance from the Japan Patent Office for a patent associated with SDC-1801, its primary TYK2/JAK1 kinase inhibitor.

Read more
3 Nov 2023 09:01

Sareum says patent notice in Japan boosts confidence in SDC-1801

(Alliance News) - Sareum Holdings PLC on Friday said it received a notice of allowance from Japan's Patent Office for a patent relating to its lead TYK2/JAK1 kinase inhibitor, SDC-1801.

Read more
9 Oct 2023 15:06

Sareum losses widen as clinical trials continue

(Sharecast News) - Biotechnology company Sareum Holdings reported a loss of £3.2m after tax in its final results on Monday, widening from last year's £2.2m due to heightened expenses from initiating clinical studies with SDC-1801, despite aligning with market anticipations.

Read more
9 Oct 2023 10:58

Sareum says earnings down but product development going well

(Alliance News) - Sareum Holdings PLC on Monday said its annual loss widened and its cash reserves are substantially reduced, but that development and testing of its medicinal products is progressing well.

Read more
6 Sep 2023 14:35

Director dealings: Blackbird, Sareum insiders pick up shares

(Sharecast News) - Blackbird found itself with a number of entries on the list of director buys on Wednesday, after a number of insiders and associates bought shares.

Read more
4 Sep 2023 09:18

Sareum begins dosing participants in phase 1a trial for SDC-1801

(Alliance News) - Sareum Holdings PLC on Monday said it has successfully started the multiple ascending dose part of its phase 1a clinical trial for its SDC-1801 drug, following approval from the safety review committee.

Read more
16 Aug 2023 13:13

Sareum flagship drug trial progressing well ahead of annual results

(Alliance News) - Sareum Holdings PLC on Wednesday said a clinical trial for its main therapeutic is continuing as planned, and it hopes to use a new prepayment facility to further enhance development.

Read more
3 Aug 2023 14:16

IN BRIEF: Sareum secures GBP5 million of funding from RiverFort Global

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Agrees terms on equity prepayment facility of up to GBP5 million with RiverFort Global Opportunities PCC Ltd, as arranged by RiverFort Global Capital Ltd, with an initial deposit of GBP2 million. This is expected on August 4, net of associated costs.

Read more
26 Jun 2023 17:33

TRADING UPDATES: New patents for Sareum; Guanajuato hails assessment

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News:

Read more
26 Jun 2023 10:54

Sareum granted new patents in China, US

(Sharecast News) - Clinical-stage biotechnology developer Sareum announced the granting of patents for its lead kinase inhibitors in China and the United States on Monday.

Read more
6 Jun 2023 13:36

IN BRIEF: Sareum doses first subjects in psoriasis drug trial

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Announces successful dosing of first test subjects in a randomised, placebo-controlled phase 1a clinical trial for lead programme SDC-1801. SDC-1801 is a dual TYK2/JAK1 kinase inhibitor and potential new therapeutic for various autoimmune diseases with an initial focus on psoriasis. The phase 1a trial will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of SDC-1801 in healthy subjects, in single and multiple ascending oral dose studies. Dosing has started in a specialist clinical unit in Melbourne, Australia. Sareum expects full safety data to become available during the first half of 2024, after which a phase 1b clinical study will commence post-haste if the Phase 1a trial obtains satisfactory results.

Read more
18 May 2023 14:31

TRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effect

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.